Dismantling the pathophysiology of asthma using imaging
- Publication Type:
- Journal Article
- Citation:
- European Respiratory Review, 2019, 28 (152)
- Issue Date:
- 2019-06-30
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
© ERS 2019. Asthma remains an important disease worldwide, causing high burden to patients and healthcare systems and presenting a need for better management and ultimately prevention and cure. Asthma is a very heterogeneous condition, with many different pathophysiological processes. Better measurement of those pathophysiological processes are needed to better phenotype disease, and to go beyond the current, highly limited measurements that are currently used: spirometry and symptoms. Sophisticated three-dimensional lung imaging using computed tomography and ventilation imaging (single photon emission computed tomography and positron emission tomography) and magnetic resonance imaging and methods of lung imaging applicable to asthma research are now highly developed. The body of current evidence suggests that abnormalities in structure and ventilatory function measured by imaging are clinically relevant, given their associations with disease severity, exacerbation risk and airflow obstruction. Therefore, lung imaging is ready for more widespread use in clinical trials and to become part of routine clinical assessment of asthma.
Please use this identifier to cite or link to this item: